MIR6744

Across TCGA pan-cancer cohorts, MIR6744 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated MIR6744 data layer.

The strongest signal is observed in pheochromocytoma and paraganglioma (PCPG), where higher MIR6744 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR6744 expression acts as an unfavorable survival marker, although some lineages such as COAD show a favorable association.

PCPG and COAD are the cancer types where MIR6744 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PCPG	DFS	Tertile	All	0.161	0.819	.004	18	view →
COAD	DFS	Tertile	II,III,IV	1.000	0.474	.018	15	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

MIR6744–PCPG (DFS)

Open the PCPG breakdown →